GxP-Agent: Process-DAG Topology for Reliable Clinical Trial Programming with LLM Agents
Researchers have developed GxP-Agent, a system to help with regulatory submissions in clinical trials. Current approaches using large language models (LLMs) fail to produce accurate results. The new system uses a graph topology to break down the task into smaller steps, executed by multiple agents with specific skills. This approach has been shown to be more reliable and accurate than previous methods, achieving 100% structural match in one benchmark and 59.2% in another.
Researchers have developed GxP-Agent, a system to help with regulatory submissions in clinical trials. Current approaches using large language models (LLMs) fail to produce accurate results. The new system uses a graph topology to break down the task into smaller steps, executed by multiple agents with specific skills. This approach has been shown to be more reliable and accurate than previous methods, achieving 100% structural match in one benchmark and 59.2% in another.
---
Why it matters: This matters because clinical trial programming is a critical bottleneck in regulatory submissions, and current LLM-based approaches are unreliable. GxP-Agent's graph topology approach has the potential to improve the accuracy and efficiency of this process, which could have significant implications for researchers and clinicians working on clinical trials.
Source: https://arxiv.org/abs/2608.16890
This article was originally published at: https://arxiv.org/abs/2608.16890